All News

The potential treatments include ivermectin, methylene blue, glucagon-like peptide-1 receptor agonists, and low-dose naltrexone.

Constantine Tam, MD, discusses zanubrutinib's efficacy in CLL/SLL, emphasizing its durability, high response rates, safety considerations, and evolving therapeutic potential in combination with other agents.

Adding HIV/AIDS to core chronic diseases is a key change.

Bispecific antibodies amivantamab and tarlatamab hold promise for patients.

The disparity highlights opportunities for pharmacists to get involved and address health disparities.

Plaintiff argues that "blacklisting” certain individuals with opioid prescriptions was unlawful.

Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia.

Pharmacists are crucial in educating patients, identifying eligible individuals, and promoting uptake of the newly expanded RSV vaccination recommendations for older adults.

Study results show that the updated BNT162b2 XBB vaccine is effective in preventing hospitalizations or emergency department visits associated with COVID-19 complications.

Muvalaplin is an oral, small molecule inhibitor that can reduce lipoprotein(a).

Individuals who refused a pneumococcal vaccine were associated with low collective responsibility and confidence in vaccine efficacy and safety.

The program develops patient-centered oncology pharmacists through comprehensive training.

Federal legislation would seek to foster development of antibiotics.

High levels of the Oscillibacter genus of bacteria were associated with reduced cholesterol.

Yi Lin, MD, PhD, highlights the importance of achieving MRD negativity in multiple myeloma, CAR T-cell therapy outcomes, and the critical role of pharmacists in patient care.

Here is an updated overview of the role of BCMA-directed therapies following the 2024 ASCO Annual Meeting and EHA Congress.

Gecacitinib is a novel inhibitor targeting both JAK and ACVR1.

Adoption barriers include insurance coverage, patient and provider education, and regulatory hurdles that require aligned initiatives across stakeholders.

Proper reporting of errors and near misses helps maintain compliance and improve patient safety.

This study evaluated factors affecting the duration of the infusion appointment times for 392 clinical trial patients.

Researchers recommend early vaccination against herpes zoster to mitigate the risks.

Pharmacists can significantly improve chronic obstructive pulmonary disease (COPD) management by promoting non-pharmacological interventions.

The monoclonal antibody demonstrates the ability to reduce the incidence and improve symptoms related to sleep disorders and psychiatric disorders such as anxiety.

Factors associated with intravenous immunoglobulin (IVIG)-related adverse events include older age, dehydration, and administration of multiple IVIG infusions.

Of these chemicals, 414 were found to be commonly used in plastics and consumer goods, such as food packaging and personal care products.

Pharmacists are encouraged to work closely with health care providers to ensure appropriate use of high-cost Intravenous immunoglobulin (IVIG) therapy for BK nephropathy.

In this episode of Public Health Matters, Christina Madison discusses the concept of reproductive justice and ensuring Black maternal health efforts are not left behind with Regina Davis Moss of In Our Own Voice.

Patient education on the risks of the long-term illness can help overcome vaccine hesitancy.

Despite the explosion of public interest in these drugs, ongoing shortages and debates over compounding made access difficult.